Acupuncture needles may speed up diabetic wound healing
NCT ID NCT07482137
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding electroacupuncture at a specific point on the leg (Zusanli, ST-36) to standard diabetes care can improve healing of foot ulcers. About 76 adults with diabetic foot ulcers will either get standard treatment alone or standard treatment plus daily electroacupuncture for four weeks. Researchers will measure wound healing and blood flow to see if the acupuncture helps.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 76 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2025
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Meet the diagnostic criteria for diabetic foot ulcers; 2. Meet the criteria for Traditional Chinese Medicine syndrome differentiation, classified as blood stasis obstructing the collateral pattern; 3. Wagner Grade 1-3, with ulcer area ranging from 2 cm² to 30 cm²; 4. Male or female, aged between 18 and 75 years; 5. Provide signed informed consent, voluntarily participate in this study, and demonstrate good compliance. Exclusion Criteria: 1. Complicated with severe diseases of the brain, liver, heart, lungs, or kidneys; 2. Pregnant women or women planning to become pregnant; 3. Glycosylated hemoglobin (HbA1c) level ≥ 9%; 4. Complicated with psychiatric disorders; 5. Complicated with genetic or infectious diseases, malignant tumors, or other severe conditions associated with a short life expectancy; 6. Concurrent participation in other clinical trials or participation within 4 weeks prior to randomization.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Diabetes foot care are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Zongda Hospital affiliated to Southeast University
RECRUITINGNanjing, Jiangsu, 210009, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.